Prevalence and significance of antiphospholipid antibodies in selected at-risk obstetrics cases: A comparative prospective study

Journal of Obstetrics and Gynaecology

Volumn 29, Issue 7, 2009, Pages 614-618

  Saha, S P ^a   Bhattacharjee, N ^a   Ganguli, R P ^a   Sil, S ^a   Patra, K K ^a   Sengupta, M ^a   Barui, G ^a   Goswami, B K ^b  

^a NORTH BENGAL MEDICAL COLLEGE   (India)

^b R G KAR MEDICAL COLLEGE   (India)

Author keywords

Antiphospholipid antibodies; Outcome; Pregnancy; Prevalence

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; ECLAMPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS DEATH; HUMAN; INTRAUTERINE GROWTH RETARDATION; LIVE BIRTH; MAJOR CLINICAL STUDY; OLIGOHYDRAMNIOS; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; RECURRENT ABORTION; SOLUTIO PLACENTAE; VAGINAL DELIVERY;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; INCIDENCE; INDIA; LUPUS COAGULATION INHIBITOR; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREVALENCE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 70350690746     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610903052073     Document Type: Article

References (30)

1. Aoki K, Hayashi Y, Hirao Y, Yagami Y. 1993. Specific antiphospholipid antibodies as a predictive variable in patients with recurrent pregnancy loss. American Journal of Reproductive Immunology 29:82-87.
2. Balasch J, Creus M, Fábregues F, Reverter JC, Carmona F, Tàssies D et al. 1996. Antiphospholipid antibodies and human reproductive failure. Human Reproduction 11:2310-2315.
3. Barbui T, Cortelazzo S, Galli M, Parazzini F. 1988. Antiphospholipid antibodies in early repeated abortions: A case controlled study. Fertility and Sterility 50:589-592.
4. Birdsall M, Pattison N, Chamley L. 2008. Antiphospholipid antibodies in pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 32:328-330.
5. Branch DW. 1998. Antiphospholipid antibodies and reproductive outcome: the current state of affairs. Journal of Reproductive Immunology 38:75-87.
6. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. 1992. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstetrics and Gynecology 80:614-620.
7. Branch DW, Silver RM, Pierangelli SS, Reading JC, Scott JR 1997. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstetrics and Gynecology 89:549-555.
8. Carreras LO, Defreyn G, Machin SJ, Vermylen J, Deman R, Spitz B et al. 1981. Arterial thrombosis, intrauterine death and lupus anticoagulant: Detection of immunoglobulin interfering with prostacyclin formation. Lancet 1:244-246. (Pubitemid 11135813)
9. el-Roeiy A, Myers SA, Gleicher N. 1990. The prevalence of autoantibodies and lupus anticoagulant in healthy pregnant women. Obstetrics and Gynecology 75:390-396.
10. Galli M, Barbui T. 2003. Antiphospholipid antibodies and pregnancy. Best Practice and Research Clinical Haematology 16:211-225.
11. Garlund B. 1984. The lupus inhibitor in thromboembolic disease and intrauterine death in the absence of systemic lupus. Acta Medica Scandinavica 215:293-298.
12. Granger KA. 1997. Review: Obstetric outcome in antiphospholipid syndrome. Lupus 6:509-513.
13. Harris EN, Spinnato JA. 1991. Should anticardiolipin tests be performed in otherwise healthy pregnant women? American Journal of Obstetrics and Gynecology 165:1272-1277.
14. Kutteh WH, Rote NS, Silver R. 1999. Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome. American Journal of Reproductive Immunology 41:133-152.
15. Kwak JYH, Gilman Sachs A, Beaman, KD, Beer AE. 1992. Autoantibodies in women with primary recurrent spontaneous abortion of unknown etiology. Journal of Reproductive Immunology 22:15-31.
16. Lockshin MD, Druzin ML, Qamar T. 1987. Antibody to cardiolipin, lupus anticoagulant and fetal death. Journal of Rheumatology 14:259-262.
17. Lockwood CJ, RomeroR, Geinberg RF, Clyne LP, Coster B, Hobin JC. 1989. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. American Journal of Obstetrics and Gynecology 161:369-373.
18. Love PE, Santoro SA. 1990. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in Non-SLE disorders. Annals of Internal Medicine 112:682-698.
19. Lynch A, Marlar R, Murphy J, Davila G, Santos M, Rutledge J et al. 1994. Antiphospholipid antibodies in predicting adverse pregnancy outcome: A prospective study. Annals of Internal Medicine 120:470-475.
20. Milliez J, Lelong F, Bayani N, Jannet D, el MedjadjiM, Latrous H et al. 1991. The prevalence of autoantibodies during thirdtrimester pregnancy complicated by hypertension or idiopathic fetal growth retardation. American Journal of Obstetrics and Gynecology 7:51-57.
21. Nilsson IM, Astedt B, Hedner U, Berezin D. 1975. Intrauterine death and circulating anticoagulant (antithromboplastin). Acta Medica Scandinavica 197:153-159.
22. Out HJ, Bruinse HW, Christiaens GC, Van Vliet M, Meilof JF, De Groot PG et al. 1991. Prevalence of antiphospholipid antibodies in patients with fetal loss. Annals of the Rheumatic Diseases 50:553-557.
23. Rai R, Cohen H, Dave M, Regan L. 1997. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies. British Medical Journal 314:253-257. (Pubitemid 27047378)
24. Ruffatti A, Orsini A, Di Lenardo L, Nardelli GB, Patrassi GM, Truscia D et al. 1997. A prospective study of fifty-three consecutive calcium heparin treated pregnancies in patients with antiphospholipid antibody-related fetal loss. Clinical and Experimental Rheumatology 15:499-505.
25. Silver RM, Porter TF, van Leeuween I, Jeng G, Scott JR, Branch DW. 1996. Anticardiolipin antibodies: clinical consequences of 'low titres'. Obstetrics and Gynecology 87:494-500.
26. Taylor M, Cauchi MN, Buchanan RR. 1990. The lupus anticoagulant, anticardiolipin antibodies and recurrent miscarriage. American Journal of Reproductive Immunology 23:33-36.
27. Triplett DA, Harris EN. 1989. Antiphospholipid antibodies and reproduction. American Journal of Reproductive Immunology 21:3-4.
28. Triplett DA, Brandt JT, Maas RL. 1985. The laboratory heterogeneity of lupus anticoagulants. Archives of Pathology and Laboratory Medicine 109:946-951.
29. Weidmann CE, Wallace DJ, Peter JB, Knight PJ, Bear MB, Klinenberg JR. 1988. Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. Journal of Rheumatology 15:74-79.
30. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC et al. 1999. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis and Rheumatism 42:1309-1311.